ValueScreener

ValueScreener company report

Bunge Global S.A. (BG)

NYSE / Consumer Defensive / Agricultural Farm Products

Share price

107.01 USD Market dataClose of Oct 15, 2026

Market capitalisation

20.56B USD Market dataClose of Oct 15, 2026
Market data
Oct 15, 2026
Filed accounts
FY2025, filed Feb 19, 2026
Ratios computed
Oct 15, 2026
Filed years
5, FY2021 to FY2025
Four kinds of sourceSEC filingCompany statementMarket dataComputedWhat each means
SEC filingFiled with the SEC
Read from a statement the company filed with the SEC, with the form, fiscal year, filing date and accession beside it.
Company statementCompany statement
What the company says about itself in a filing: an 8-K item, the auditor, its own segment names.
Market dataMarket data
Prices, market value and what analysts publish, with the date they are as of.
ComputedComputed by ValueScreener
Worked out by us from the other three, with the inputs and the formula one press away. A score is a research output, not a rating or a recommendation.
Reading

1 of 10

Overview

What the business is, what it costs, and how it reads on four questions.

Market dataSEC filingComputed

Four questions, at a glance

Quality

Return on invested capital, after tax

4.3% Computed

From the FY2025 filing

Read quality

Valuation

Price to earnings

21.62x Computed

FY2025 accounts, priced at the latest close

Read valuation

Cash generation

Free cash flow yield

-4.9% Computed

FY2025 accounts, priced at the latest close

Read cash generation

Revenue and net income, by fiscal year

FY2016 Revenue: 42.68B USDFY2016 Net income: 745.0M USDFY2017 Revenue: 45.79B USDFY2017 Net income: 160.0M USDFY2018 Revenue: 45.74B USDFY2018 Net income: 267.0M USDFY2019 Revenue: 41.14B USDFY2019 Net income: -1.28B USDFY2020 Revenue: 41.40B USDFY2020 Net income: 1.15B USDFY2021 Revenue: 59.15B USDFY2021 Net income: 2.08B USDFY2022 Revenue: 67.23B USDFY2022 Net income: 1.61B USDFY2023 Revenue: 59.54B USDFY2023 Net income: 2.24B USDFY2024 Revenue: 53.11B USDFY2024 Net income: 1.14B USDFY2025 Revenue: 70.33B USDFY2025 Net income: 816.0M USD
Revenue Net income10 fiscal years; a year whose statement names no SEC filing is market data, and the table in Filings says which.
Named tests met
0 of 30 Which tests
The business, and the score behind its five axes

The reading, in brief

Is it cheap

Price to earnings is 21.62x at the close of 2026-10-15 on FY2025 figures; the lines are 15.00x (Graham's defensive ceiling) and, by market convention, 10.00x, 25.00x and 40.00x, and this sits between 15.00x and 25.00x.

Today, against the Consumer Defensive sector (135 companies), 21.62x sits at the 53rd percentile; the middle half of that group runs from 13.84x to 33.63x.

Is it good

Return on invested capital was 4.3% in FY2025, in the band labelled "Likely below the cost of capital" (below 8.0%), on lines anchored on Damodaran's cost-of-capital data, suggesting returns below the usual cost of the capital employed.

Today, against the Consumer Defensive sector (102 companies), 4.3% sits at the 35th percentile; the middle half of that group runs from 2.7% to 14.1%.

Is it safe

Debt to equity was 1.00 in FY2025, in the band labelled "Leveraged" (1.00 to 2.00), on lines anchored on Graham's defensive-investor criteria.

Today, against the Consumer Defensive sector (131 companies), 1.00 sits at the 60th percentile; the middle half of that group runs from 0.35 to 1.58.

Year by year against peers
Whether Bunge Global S.A.'s return on invested capital stayed above the median of the Consumer Defensive sector, year by year. (FY2022 to FY2025, 4 fiscal years of Bunge Global S.A. with a comparable figure)
The direction
Which way Bunge Global S.A.'s gross margin has moved, and how steadily. (FY2016 to FY2025, 10 filed years of Bunge Global S.A.)
What could explain it
What in Bunge Global S.A.'s filed statements could explain the movements. (6 readings drawn from the statement lines Bunge Global S.A. filed)
What to check next
What to check next on Bunge Global S.A., and where in its filings. (7 questions for Bunge Global S.A.)
In one paragraph
One paragraph on Bunge Global S.A.'s returns, cash, balance sheet and price. (13 of sixteen figures read for Bunge Global S.A.)

These are BG’s filed figures. The research desk says what they mean, against peers and its own years, with what to check next.

Research BGPart of Serious. New accounts start with 30 days of Professional, free, no card.

2 of 10

What changed

The newest filing, what it moved, and when the next one is due.

SEC filingCompany statement

The newest accounts on file are the FY2025 annual report: 10-K, filed Feb 19, 2026, accession 0001628280-26-009842.

3 of 10

Quality

The returns the business earns on its capital, and the margins behind them.

SEC filingComputed

Bunge Global S.A: returns on capital and margins, each with its source
FigureValue, source and document
Return on invested capital, after tax4.3% ComputedFY2025 10-K, filed Feb 19, 2026, 0001628280-26-009842
Return on equity5.1% ComputedFY2025 10-K, filed Feb 19, 2026, 0001628280-26-009842
Return on capital employed, pre-tax
Why n/a

We do not hold this figure for this company, so there is nothing to show.

n/a ComputedFY2025 10-K, filed Feb 19, 2026, 0001628280-26-009842
Return on assets1.8% ComputedFY2025 10-K, filed Feb 19, 2026, 0001628280-26-009842
Gross margin4.8% ComputedFY2025 10-K, filed Feb 19, 2026, 0001628280-26-009842
Operating margin
Why n/a

No operating income line is filed for this year.

n/a ComputedFY2025 10-K, filed Feb 19, 2026, 0001628280-26-009842
Net margin1.2% ComputedFY2025 10-K, filed Feb 19, 2026, 0001628280-26-009842
BG 1.2%
TSN 0.9%PFGC 0.5%JBS 2.4%USFD 1.7%KHC -23.4%
-23.4%2.4%
Net margin: BG against the 5 companies named under Valuation context, each as filed for its own latest year. Placement only: no average is drawn.

4 of 10

Financial strength

What it owes against what it owns, and whether it can meet what falls due.

SEC filingComputedCompany statement

Bunge Global S.A: leverage, liquidity and distress, each with its source
FigureValue, source and document
Debt to equity1.00 ComputedFY2025 10-K, filed Feb 19, 2026, 0001628280-26-009842
Current ratio1.61 ComputedFY2025 10-K, filed Feb 19, 2026, 0001628280-26-009842
Quick ratio0.74 ComputedFY2025 10-K, filed Feb 19, 2026, 0001628280-26-009842
Interest coverage
Why n/a

No operating income line is filed for this year.

n/a ComputedFY2025 10-K, filed Feb 19, 2026, 0001628280-26-009842
Altman Z-score
Why n/a

We do not hold this figure for this company, so there is nothing to show.

n/a ComputedClose of Oct 15, 2026 · FY2025 10-K, filed Feb 19, 2026, 0001628280-26-009842
Net debt13.83B ComputedFY2025 10-K, filed Feb 19, 2026, 0001628280-26-009842
Total assets 44.53BTotal liabilities 27.16BShareholders' equity 15.90BOwnsOwes, and equity
Total assets Total liabilities Shareholders’ equity
The balance sheet, line by line

Financial health

What Bunge Global S.A owned and owed at the end of fiscal 2025, from the balance sheet it filed (10-K, filed Feb 19, 2026, 0001628280-26-009842).

Bunge Global S.A: balance sheet position
Total assets44.53B FiledFY2025 10-K, filed Feb 19, 2026
Total liabilities27.16B FiledFY2025 10-K, filed Feb 19, 2026
Shareholders' equity15.90B FiledFY2025 10-K, filed Feb 19, 2026
Cash2.00B FiledFY2025 10-K, filed Feb 19, 2026
Total debt15.83B FiledFY2025 10-K, filed Feb 19, 2026
Net debt13.83B
Current ratio1.61
Debt to equity1.00
  • Interest cover: FY2025: No operating income line is filed for this year.

Read from the filed balance sheet for each year, with the income statement of the same year supplying operating profit where a ratio needs it. Nothing here is a view on whether this company is sound.

5 of 10

Valuation context

What the market charges for it, against its own record and companies like it.

Market dataSEC filingComputed

Bunge Global S.A: what the market charges, each with its source
FigureValue, source and document
Price to earnings21.62x ComputedClose of Oct 15, 2026 · FY2025 10-K, filed Feb 19, 2026, 0001628280-26-009842
P/E on trailing twelve months28.46x ComputedClose of Oct 15, 2026 · Trailing four quarters, each as known on the day; the quarterly filings are listed under Filings
Price to book1.12x ComputedClose of Oct 15, 2026 · FY2025 10-K, filed Feb 19, 2026, 0001628280-26-009842
Price to sales0.25x ComputedClose of Oct 15, 2026 · FY2025 10-K, filed Feb 19, 2026, 0001628280-26-009842
Enterprise value to EBIT18.45x ComputedClose of Oct 15, 2026 · FY2025 10-K, filed Feb 19, 2026, 0001628280-26-009842
Enterprise value to EBITDA
Why n/a

We do not hold this figure for this company, so there is nothing to show.

n/a ComputedClose of Oct 15, 2026 · FY2025 10-K, filed Feb 19, 2026, 0001628280-26-009842
Price to earnings over growth
Why n/a

We do not hold this figure for this company, so there is nothing to show.

n/a ComputedClose of Oct 15, 2026 · FY2025 10-K, filed Feb 19, 2026, 0001628280-26-009842
Diluted earnings per share4.91 USD FiledFY2025 10-K, filed Feb 19, 2026, 0001628280-26-009842
Graham number103.15 USD ComputedFY2025 10-K, filed Feb 19, 2026, 0001628280-26-009842

We publish no fair value or price target of our own. Value BG on your own assumptions in the DCF workbench, starting from the filed figures.

Its own record, and companies like it

Valuation

What the market charges for Bunge Global S.A today, and the multiples it has carried. No value of ours: the figures are the filings’ and the market’s.

Bunge Global S.A: valuation
Share price107.01 USD
Market capitalisation20.56B USD
Enterprise value to EBITDAn/a
Graham number103.15 USD
Diluted earnings per share, FY20254.91 USD

Price to earnings on trailing twelve months, a different basis from the fiscal-year P/E above, since Aug 1, 2024: low 7.46x, median 9.65x, high 34.76x, latest 28.46x. 552 trading days with a meaningful ratio. Each close over the trailing twelve months of earnings as known that day: a quarter counts from the day it was filed.

Companies like Bunge Global S.A

  1. Tyson Foods, Inc. (TSN)Market cap 19.01B USD
  2. Performance Food Group Company (PFGC)Market cap 15.28B USD
  3. JBS N.V. (JBS)Market cap 28.21B USD
  4. US Foods Holding Corp. (USFD)Market cap 21.95B USD
  5. The Kraft Heinz Company (KHC)Market cap 27.61B USD

Same sector (Consumer Defensive) and size band (Large, 10B to 200B), nearest in market value, net margin and current ratio. Each of those counts equally, by how many of the companies considered sit between the two on it. Closest first: the order is likeness and nothing else.

6 of 10

Cash generation

Whether profit arrives as cash, and what is paid back to shareholders.

SEC filingComputed

Bunge Global S.A: cash generation and what is paid out, each with its source
FigureValue, source and document
Free cash flow yield-4.9% ComputedClose of Oct 15, 2026 · FY2025 10-K, filed Feb 19, 2026, 0001628280-26-009842
Free cash flow-879.0M USD ComputedFY2025 10-K, filed Feb 19, 2026, 0001628280-26-009842
Free cash flow margin-1.3% ComputedFY2025 10-K, filed Feb 19, 2026, 0001628280-26-009842
Dividend yield2.6% ComputedClose of Oct 15, 2026 · FY2025 10-K, filed Feb 19, 2026, 0001628280-26-009842
Payout ratio56.3% ComputedFY2025 10-K, filed Feb 19, 2026, 0001628280-26-009842
FY2016 Free cash flow: -338.0M USDFY2016 Net income: 745.0M USDFY2017 Free cash flow: -2.64B USDFY2017 Net income: 160.0M USDFY2018 Free cash flow: -1.76B USDFY2018 Net income: 267.0M USDFY2019 Free cash flow: -1.33B USDFY2019 Net income: -1.28B USDFY2020 Free cash flow: -3.90B USDFY2020 Net income: 1.15B USDFY2021 Free cash flow: -3.29B USDFY2021 Net income: 2.08B USDFY2022 Free cash flow: -6.10B USDFY2022 Net income: 1.61B USDFY2023 Free cash flow: 2.19B USDFY2023 Net income: 2.24B USDFY2024 Free cash flow: 524.0M USDFY2024 Net income: 1.14B USDFY2025 Free cash flow: -879.0M USDFY2025 Net income: 816.0M USD
Free cash flow Net incomeProfit that arrives as cash stands level with net income; a gap year after year is worth reading about.

7 of 10

Filings

Every figure, the year it is for and the document it was read from.

SEC filingMarket data

The filed figures

Computed from the accounts this company filed with the SEC and, in a ratio with a price in it, the last close, dated on this page. Every filed figure below carries the fiscal year and the filing date its accounts were read from, and every blank carries the reason it is blank. Nothing here is a view on this company.

Bunge Global S.A.: the eight ratios, with the fiscal year and filing date behind each.
FigureValueYearAs of
21.62xFY2025Oct 15, 2026
1.12xFY2025Oct 15, 2026
18.45xFY2025Oct 15, 2026
-4.9%FY2025Oct 15, 2026
4.3%FY2025Feb 19, 2026
2.6%FY2025Oct 15, 2026
1.00FY2025Feb 19, 2026
1.61FY2025Feb 19, 2026
0.25xFY2025Oct 15, 2026
n/aFY2025Oct 15, 2026
n/a This figure compares a year against the one before it, and we hold one filed year for this company.
n/aFY2025Oct 15, 2026
n/a We hold no figure here and no stored reason for its absence. The gap is ours, not the company's.
-1.31FY2025Feb 19, 2026
3/9FY2025Feb 19, 2026

The figures are computed from the accounts for fiscal 2025, the newest full year on file. 5 filed fiscal years on record, FY2021 to FY2025, from SEC EDGAR. Prices as of Oct 15, 2026. Ratios recomputed Oct 15, 2026. Two facts, because a recompute is not a fresh quote.

The year and the filing date name the statement each figure’s accounts are read from, and they stand even where the figure itself could not be computed: the line beneath a blank says what that statement did not carry. A figure’s name opens its formula and the filings behind it; a statement that names no SEC filing has no filing date, and reads n/a.

Ten years of filed figures, year by year

Ten years of filed figures

10 fiscal years, FY2016 to FY2025. 5 read from the annual reports Bunge Global S.A filed with the SEC, each naming its filing; the rest from statements that name none, which are market data. Amounts in USD, as reported.

Bunge Global S.A: revenue, earnings, free cash flow and returns, by fiscal year, with the filing each year was read from
YearRevenueOperating incomeNet incomeEPS, dilutedFree cash flowOperating marginReturn on equityFiling
FY202570.33B1.76B816.0M4.91-879.0Mn/a5.1%10-K, Feb 19, 20260001628280-26-009842
FY202453.11B2.00B1.14B7.99524.0Mn/a11.5%10-K, Feb 20, 20250001996862-25-000008
FY202359.54B3.57B2.24B14.872.19Bn/a20.7%10-K, Feb 22, 20240001996862-24-000007
FY202267.23B2.47B1.61B10.51-6.10Bn/a17.4%10-K, Feb 22, 20240001996862-24-000007
FY202159.15B2.81B2.08B13.64-3.29Bn/an/a10-K, Feb 22, 20240001996862-24-000007
FY202041.40B1.43B1.15B7.71-3.90B3.5%18.9%Market data, supplied Oct 15, 2026accession n/a
FY201941.14B-809.0M-1.28B-9.34-1.33B-2.0%-21.6%Market data, supplied Oct 15, 2026accession n/a
FY201845.74B843.0M267.0M1.64-1.76B1.8%4.3%Market data, supplied Oct 15, 2026accession n/a
FY201745.79B328.0M160.0M0.89-2.64B0.7%2.2%Market data, supplied Oct 15, 2026accession n/a
FY201642.68B1.13B745.0M5.01-338.0M2.6%10.4%Market data, supplied Oct 15, 2026accession n/a
  • Revenue, compound annual growth FY2016 to FY2025: 5.7%
  • Earnings, compound annual growth FY2016 to FY2025: 1.0%
  • Earnings per share, compound annual growth FY2016 to FY2025: -0.2%
  • Free cash flow: Free cash flow was not positive in both 2016 and 2025, so a compound rate across the window is not defined. Both figures are in the table.

Every figure in this section is a line of a filed annual statement or a ratio of two of them. Nothing here is estimated or smoothed. Earnings per share filed before a share split are put on today's share count, and say so. Nothing here is a verdict on the company.

8 of 10

Risks and guardrails

The accounting screens, the published tests, and the lines you can set to be told.

ComputedCompany statement

Bunge Global S.A: accounting screens and published tests, each with its source
FigureValue, source and document
Beneish M-score-1.31 ComputedFY2025 10-K, filed Feb 19, 2026, 0001628280-26-009842
Piotroski F-score3/9 ComputedFY2025 10-K, filed Feb 19, 2026, 0001628280-26-009842
Named tests met0 of 30 Computed
Beta0.09 ComputedClose of Oct 15, 2026

The named tests

Of 30 tests value investors published: 0 met, 29 not met, 1 we could not complete. Counts, never a score: a single figure would have to decide that meeting one investor’s criteria and meeting another’s are worth the same.

Which tests, by name(all 30)
Meets
None of the named tests.
Does not
Defensive investor (Benjamin Graham); Deep value; Large cap, low P/E; Earnings yield and ROIC (Joel Greenblatt); High F-score, low P/B (Joseph Piotroski); Three forensic scores; Low PEG, low debt (Peter Lynch); High returns and growth; Gross margin, turnover (Robert Novy-Marx); High yield, low payout; Dividends and buybacks; Low beta, profitable; ROIC at or above WACC; Near the 52-week low; Z-score and coverage (Edward Altman); Two thirds of NCAV (Benjamin Graham); P/E times P/B (Benjamin Graham); High returns, low debt; Owner earnings yield; High return on tangibles; Low P/S, rising earnings (James O'Shaughnessy); Book or below, low debt (Walter Schloss); Cash-covered dividend; Tangible book or below; Cash-flow yield and ROIC; Clean books, high ROIC; Cheapest quarter on P/E (David Dreman); Cheapest quarter on P/B (David Dreman); Low P/E, growth, yield (John Neff)
Not measured
EV/EBITDA and coverage. A test with a figure we could not read is incomplete, never met and never failed.
Figures we could not read(4)
  • Altman Z-Score: We do not hold this figure for this company, so there is nothing to show.
  • PEG Ratio: We do not hold this figure for this company, so there is nothing to show.
  • EV/EBITDA: We do not hold this figure for this company, so there is nothing to show.
  • Interest Coverage: No operating income line is filed for this year.

9 of 10

Declared positions

Whether anybody here owns this company.

Positions declared by the founder: no holding in any company shown here, as of October 3, 2026.

10 of 10

Next step

What to do with what you have read.

A thesis is your reason for owning it, in your words, with the figures that must stay true. Checking those figures every night against the newest filed accounts, and telling you once when one breaks, is what the subscription adds.

More on this company

What this cannot tell you

  • 4 figures could not be read on this company, among them Altman Z-Score, PEG Ratio, EV/EBITDA. Each blank in the table above names the rest, with its reason. 1 named test comes back incomplete because of them, which is neither met nor missed.
  • We hold 5 filed fiscal years rather than 10, so the run above is shorter than a full decade and is counted as what it is.

And the one that is true of all of it: This is what the numbers say today. It cannot tell you the day one of them stops being true. Nothing here can, because the reasons are not written down.

Running this once is arithmetic on public documents and you are welcome to it. Writing down why you own each company, in your own words and with the numbers that have to stay true for it to hold, and then having those numbers re-checked every night against the newest filed accounts, and against the latest close where a rule watches a price, is Professional, the plan a new account starts on for 30 days, one trial per person. It writes to you the day one breaks, and stays quiet when nothing does. The check runs every night at 23:30 UTC. A filing is picked up the night after it is published.

No card. 30 free days, and nothing is charged unless you choose a plan.

Analyze your own portfolio

ValueScreener · valuescreener.ai · Computed from accounts filed with the SEC by this company, read from EDGAR, and from dated closing prices. On this page a filed figure opens into its formula, its inputs and the statement, fiscal year and filing date it was read from, and a price into the day of its close. A figure that cannot show that trail says so.

A computation on accounts filed with the SEC, not a recommendation and not advice. Past filings do not indicate future results. Risk disclaimer.

Once a week, what changed in the filings of US-listed companies, why it can matter to a thesis, and what deserves a closer review. Grounded in filings, not market noise.

Site map
  • Android app coming soon
  • iPhone app coming soon
ValueScreener

Discover companies, research each one to its filings, track what matters, and take your work into your own spreadsheet.

ValueScreener is a trading name of Oliva Real Estate Technologies LLC, a Delaware limited liability company. Legal notices: legal@valuescreener.ai. © 2026 Oliva Real Estate Technologies LLC. All rights reserved.

Risk disclaimer. This service is provided for research and education only. Nothing on it is investment advice, a recommendation, or an offer to buy or sell any security. Capital is at risk, and past performance does not indicate future results. Figures come from filed accounts and may be incomplete, delayed or later restated, so verify a number against the filing before you act on it.